Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adhera Therapeutics
Adhera Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Prestalia
Perindopril arginine
,
Amlodipine besylate
2015-01-21
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
myoclonic epilepsies
,
syndrome
Aglatimagene besadenovec
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
Intermedine
adrenal insufficiency
Isoxaflutole
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
covid-19
,
virus diseases
,
sickle cell anemia
,
erectile dysfunction
,
systemic lupus erythematosus
,
psoriatic arthritis
,
arthritis
,
prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
urinary bladder neoplasms
,
uterine neoplasms
,
liver neoplasms
,
kidney neoplasms
,
uterine cervical neoplasms
,
colonic neoplasms
,
hematologic diseases
,
hematopoietic stem cell transplantation
,
bone marrow transplantation
,
acromegaly
,
cardiovascular diseases
,
rare diseases
,
oncogenes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use